Agenus (AGEN) Acquisitions (2014 - 2022)

Agenus' (AGEN) quarterly Acquisitions came in at -$735000.0 in Q4 2022, down 213.08% quarter-over-quarter from $650000.0 in Q2 2022.

Agenus (AGEN) Acquisitions (2014 - 2022) Analysis & Trends

Agenus' Acquisitions history runs 4 years deep, the most recent figure standing at -$735000.0 for Q4 2022.

On a quarterly basis, Acquisitions changed N/A year-over-year to -$735000.0 in Q4 2022; TTM through Dec 2022 was $2.9 million, a N/A change from a year earlier, with the FY2022 full-year figure at $2.9 million, changed N/A from the prior year.
Acquisitions retreated to -$735000.0 in Q4 2022 per AGEN's latest filing, from $650000.0 in the prior quarter.
Across five years, Acquisitions topped out at $3.0 million in Q1 2022 and bottomed at -$735000.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Agenus	184.05 Mn	177.29 Mn	33.74 Mn	-

Download Data